AstraZeneca gets approval for asthma drug
November 15, 2017
Fasenra, AstraZeneca’s add-on maintenance treatment for patients with severe asthma, has received U.S. Food and Drug Administration approval. Fasenra is approved for patients 12 and older with an eosinophilic phenotype, […]
chat_bubble0 Comment
visibility682 Views
Premier Digital Partners
© 2024 Delaware Business Times
